Quick answers
FAQ
Guides & FAQs
Step 1
Consult & Supply
Contact our compounding team with your target dosing requirements and supply your approved liquid injectables. We will conduct a rapid clinical assessment to confirm compatibility and finalize your exact therapeutic profile.
Step 2
Precision Compounding
Our clinical pharmacists take over. Utilizing our patented, low-temperature volumetric dispensing platform, we safely convert your injectables into exact-dose Mucosal Thin Films (MTFs) within our non-sterile compounding lab at Temasek Lifesciences Laboratory or at our cGMP facility at Esco Aster.
Step 3
Receive & Deploy
We return your finished MTFs in moisture-resistant, unit-dose aluminium sachets. Your clinical team can immediately administer the trauma-free films at the point of care, completely bypassing cold-chain storage and hazardous sharps disposal.
Process and workflow
Workflow
Resources
Guides and resources
A novel unit‐dose approach for the pharmaceutical compounding of an orodispersible film
This foundational peer-reviewed study introduces the scientific framework behind PharLyfe+'s core manufacturing technology. It demonstrates how our proprietary unit-dose volumetric dispensing method resolves the severe content uniformity challenges associated with legacy continuous solvent-casting. By successfully decoupling fluid viscosity from dosing precision, the research validates that extemporaneously compounded mucosal films can achieve exact-dose, regulatory-compliant standards for individualized pharmacotherapy.
Buccal Films: A Review of Therapeutic Opportunities, Formulations & Relevant Evaluation Approaches
This comprehensive review explores the expansive therapeutic potential of mucoadhesive buccal films, highlighting their superior patient acceptability and their critical advantage in treating vulnerable populations, such as geriatric patients suffering from dysphagia. The paper evaluates various formulation strategies—including over thirty mucoadhesive polymers and manufacturing methods like solvent casting—while emphasizing the critical need for physiologically relevant in vitro evaluation approaches to successfully translate these patient-centric dosage forms into the commercial marketplace.
Patent: Volumetric Dispensing for Extemporaneous Orodispersible Films
Our core manufacturing technology is legally protected by a robust intellectual property portfolio. This patent details our proprietary low-temperature <40 degrees celsius volumetric dispensing method, which successfully decouples fluid viscosity from content uniformity. By overcoming the physical limitations of legacy solvent-casting, this patented process enables the precise, rapid compounding of both stable and thermolabile therapeutics into exact-dose mucosal films.
Reach Out
Contact
How can we help?